(1 - 11 from 11
)
Cara The…utics Announces Positive Results From Phase 2 Trial in...
... our lead I.V. CR845 program in acute pain," said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara The…utics.
Cara The…utics Achieves Milestone Payments From Japan
studies with I.V. CR845 in uremic pruritus," said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara The…utics.
sorted by relevance / date